What Researchers Did
Researchers conducted a pilot study to evaluate the safety, tolerability, and physiological responses of combined hyperbaric oxygen therapy and low-temperature infrared radiation (HBOIR) at 1.4 bar in healthy participants.
What They Found
The pilot study found that HBOIR at 1.4 bar was safe and well tolerated in healthy participants. However, it led to moderate cardiovascular changes and an increase in body temperature.
What This Means for Canadian Patients
While this pilot study suggests HBOIR at 1.4 bar is safe for healthy individuals, further research is needed to determine its efficacy and safety in Canadian patients with conditions like peripheral arterial disease or wound healing disorders. If proven effective, this combined therapy could potentially offer a new approach to improve tissue oxygenation for various medical conditions.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a pilot study, this research was limited to healthy participants and did not assess the efficacy or long-term effects of HBOIR in patients with specific medical conditions.